$HOOD

Robinhood's New Role in the IPO Process Could Have It Earning Fees Like an Investment Bank

Robinhood (HOOD) will underwrite Oura's IPO, marking its first time as a direct underwriter. This move expands its role beyond stock trading, generating direct revenue. Robinhood's revenue grew 44% YoY to $776M last quarter, with a P/E ratio of 51. Oura aims to raise $3B in its IPO.

Original reporting
Published Sep 11, 2026, 2:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 2:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Robinhood's New Role in the IPO Process Could Have It Earning Fees Like an Investment Bank — source image
Decision brief

The 30-second read

$HOODBullishLow
01

Why it matters

The underwriting role could diversify revenue but may face operational and regulatory hurdles.

02

Market read

Introduces a new fee‑generating business for Robinhood, potentially influencing fintech competition.

03

What to watch

Regulatory approval for Robinhood to underwrite and the success of the Oura IPO itself are uncertain.

Relevance 7/10Novelty 7/10Timing: as of Sep 11 2026

Background

Robinhood has been expanding beyond pure brokerage, adding banking‑like services and new revenue lines.

Company-level read

Ticker impact

$HOODBullishMedium confidence
Context

Robinhood will serve as a direct underwriter for the Oura IPO, selling shares directly to its customers.

Expected impact

Potential modest upside as investors price in new fee revenue, but valuation already high may limit move.

Evidence & confidence

The new underwriting role is a material business development, yet the impact depends on Oura's IPO size and execution.

Market effects

Brokerage and fintech sector may see increased competition as platforms add underwriting services.

U.S. retail brokerage market could experience slight shift in fee revenue distribution.

Limited to U.S. markets; Oura IPO size modest relative to global capital raises.

Counterpoint

The underwriting fee may be marginal and could distract from Robinhood's core trading business.

Key entities

  • Robinhood Markets

    NASDAQ‑listed brokerage platform expanding into underwriting.

  • Oura

    Health‑tech firm planning a $3 billion IPO.

Related articles

$HOODMed

Evercore ISI Upgrades Robinhood Markets (HOOD) to Outperform wit

Evercore ISI upgraded Robinhood Markets (HOOD) to Outperform with a $130 price target, citing strong user and deposit growth. HOOD's stock rose 0.32% in pre-market trading to $109.37. The company's P/S ratio is 20x, above historical and industry norms, indicating high growth expectations. Insider selling was significant, while institutional interest was mixed.

$ASTSMed

Bristol-Myers Squibb Slips Despite Fresh Trial Wins

AST Space Mobile (ASTS) and Robinhood (HOOD) saw pre-market gains. ASTS rose 3% after Deutsche Bank upgraded it to Buy with a $93 target. HOOD gained 0.4% following an Outperform rating and $130 target from Evercore ISI. Both stocks have underperformed recently, with ASTS down 48% in 6 months and HOOD down 3.6% YTD.